Prospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jan 7, 2017; 23(1): 135-140
Published online Jan 7, 2017. doi: 10.3748/wjg.v23.i1.135
Figure 1
Figure 1 Correlation of serum trefoil factor-3 concentrations with Simple Endoscopic Score for Crohn’s disease scores. Samples were collected from 29 patients before and after the induction therapy with anti-TNF-α agents (n = 58). TFF-3: Trefoil factor-3; SES-CD: Simple Endoscopic Score for Crohn’s disease.
Figure 2
Figure 2 Individual changes in serum trefoil factor-3 during anti-TNF-α therapy in patients with or without successful mucosal healing as assessed by endoscopy. MH: Mucosal healing; TFF-3: Trefoil factor-3.
Figure 3
Figure 3 Correlation of fecal calprotectin with Simple Endoscopic Score for Crohn’s disease and serum trefoil factor-3 in 10 patients assessed before and after the induction therapy with anti-TNF-α agents (n = 20). TFF-3: Trefoil factor-3; SES-CD: Simple Endoscopic Score for Crohn’s Disease; FC: Fecal calprotectin.